1947年，肺结核无异于绝症，医生嘱咐他多呼吸新鲜空气和注意有规律的日常饮食。但市面上出现了一种新的试验性药物——链霉素。
In 1947 there was no cure for TB - doctors prescribed fresh air and a regular diet - but there was a new, experimental drug on the market, streptomycin.
目的评价卷曲霉素、左氧氟沙星及对氨基水杨酸钠联合化疗方案在耐多药肺结核治疗中的效果。
Objective To evaluate the clinical efficacy of a combination therapy with capreomycin , levofloxacin and sodium aminosalicylate in the treatment of multi-drug resistant pulmonary tuberculosis.
评价含利福霉素钠注射液（SV）方案治疗肺结核的疗效和安全性。
To evaluate the therapeutic effect and safety of the rifamycin sodium injection (SV) in treatment of patients with pulmonary tuberculosis.
目的发现新安莎类抗生素，康乐霉素A体外抗结核活性。
Objective To explore the bioactivities of Kanglemycin A, a novel ansamycin group antibiotic against Mycobacteria tuberculosis (TB) in vitro.
目的分析结核分支杆菌对链霉素药物的敏感性状况，为结核病的防治提供理论依据。
Objective to study on the situation and trend of Streptomycin resistance for tuberculosis and provide the basis for tuberculosis prevention and treatment.
在3到4个月的治疗以后，结核杆菌变得对链霉素耐药，结核病又回到了悲剧的轨道。
After three to four months of treatment, tubercle bacilli became resistant to streptomycin, and the disease resumed its tragic course.
方法：采用含卷曲霉素、结核清、氧氟沙星、复合利福平及吡嗪酰胺等抗结核药物方案对耐多药肺结核患者进行治疗。
Methods: The tuberculosis of multi-drug resistance were treated with capreomycin, pasinizide, ofloxacin, rifampin compound and pyrazinamide for one year.
方法：采用含卷曲霉素、结核清、氧氟沙星、复合利福平及吡嗪酰胺等抗结核药物方案对耐多药肺结核患者进行治疗。
Methods: The tuberculosis of multi-drug resistance were treated with capreomycin, pasinizide, ofloxacin, rifampin compound and pyrazinamide for one year.
应用推荐